Integral Diagnostics Share Price and Company Fundamentals
Last traded: Today at 2:58 AM
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company provides its services through 64 radiology clinics, including 20 hospital sites. Integral Diagnostics Limited was incorporated in 2008 and is headquartered in Melbourne, Australia.
Key Metrics
PE ratio
31.54
PB ratio
4.00
Dividend yield
1.79%
Beta
1.05
Market cap
$1.01B
Enterprise value
$1.3B
Company profile
| Primary activities | Provider of medical imaging services across Australia and New Zealand. |
|---|---|
| Industry / Sector | Diagnostics & Research / Healthcare |
| Full time employees | 1149 |
| Website | http://www.integraldiagnostics.com.au |
| Mailing address | 45 William Street Suite 9.02, Level 9 Melbourne VIC 3000 Australia |
| Phone / Fax | 61 3 5339 0704 / 61 3 9321 4926 |
| Share registry | COMPUTERSHARE INVESTOR SERVICES PTY LIMITED |
Dividends
More: Integral Diagnostics Dividend history, yield and payout ratio
Dividend yield
1.79%
Dividend amount
$0.09
Payout ratio
58.82%
5Y Avg. yield
3.07%
Integral Diagnostics paid $0.09 dividend and the ex-dividend date was 01 Mar 2021.The dividend payout ratio is 58.82%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.IDX dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
IDX's forward dividend amount is $0.1 and the forward dividend yield is 1.79%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
Company Executives
As of Aug 2021, following are the company executives and directors listed on Integral Diagnostics.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Ian Kadish M.B.A., MBBCh, MBA | CEO, MD & Director | 57 | 804.61k |
| Ms. Anne Lockwood | CFO & Chief Commercial Officer | 551.5k | |
| Dr. Jacqueline Milne MBBS | Exec. Director | 795.06k | |
| Mr. Paul McCrow | Chief Operating Officer | ||
| Mr. Julian Gully | Chief Information Officer | ||
| Ms. Mica Duncalfe | Chief People Officer | ||
| Dr. Nazar Bokani | Exec. Director | ||
| Dr. Lisa Sorger MBBS | Chief Medical Officer |
Profitability and management effectiveness
Profit margin
10.18%
Operating margin
15.98%
Return on assets
5.21%
Return on equity
13.38%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Integral Diagnostics is 1.01B and its enterprise value is 1.3B. The enterprise value to revenue ratio of IDX is 4.13.
The IDX's stocks Beta value is 1.05 making it 5% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Integral Diagnostics (IDX)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Integral Diagnostics (ASX:IDX) Frequently Asked Questions
1. What is Integral Diagnostics's Stock Symbol?
Integral Diagnostics trades on ASX under the ticker symbol "IDX".
2. What is Integral Diagnostics's stock price today?
One share of IDX stock can currently be purchased for approximately $5.11.
3. How can I contact Integral Diagnostics?
Integral Diagnostics's mailing address is 45 William Street Suite 9.02, Level 9 Melbourne VIC 3000 Australia. The company can be reached via phone at 61 3 5339 0704.
4. What is Integral Diagnostics's official website?
The official website of Integral Diagnostics is http://www.integraldiagnostics.com.au.
5. Which share registry manages Integral Diagnostics's stock?
Integral Diagnostics's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.